查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球艾滋病毒/艾滋病诊断市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测
市场调查报告书
商品编码
1305188

全球艾滋病毒/艾滋病诊断市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测

Global HIV/AIDS Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 156 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2030年，全球HIV/AIDS诊断市场需求将从2022年的62.2亿美元达到近137.5亿美元，2023-2030年的复合年增长率为10.42%。

HIV/AIDS诊断是指用于检测人类免疫缺陷病毒（HIV）的存在和监测获得性免疫缺陷综合征（AIDS）进展的试验和方法。这些诊断方法包括各种实验室检测和护理点（POC）设备，可检测HIV抗体或抗原、病毒载量和CD4 T细胞计数。

市场动态：

尽管在HIV/AIDS的预防和治疗方面取得了重大进展，但该疾病仍是全球健康领域的一大挑战。据估计，2019年全球有3800万艾滋病毒/艾滋病感染者（世卫组织报告）。HIV/AIDS的高发病率推动了对能够准确检测和监测该疾病的诊断产品的需求。随着中低收入国家医疗保健系统的改善和普及，越来越多的人接受艾滋病毒/艾滋病检测。这导致了对经济实惠、准确和易于使用的诊断测试的更大需求。诊断技术的最新进展推动了更灵敏、更特异的HIV/AIDS检测技术的发展。例如，新的POC设备可以快速、准确地提供结果，从而可以更早地进行诊断和治疗。艾滋病毒/艾滋病的自我检测正变得越来越流行，尤其是在艾滋病毒/艾滋病高发国家。自我检测允许个人在家中进行自我检测，而无需医疗服务提供者。由于自我检测试剂盒准确、价格低廉且易于使用，因此自我检测试剂盒的需求量不断增加。各国政府和国际组织正在投资改善艾滋病毒/艾滋病的诊断和治疗。这包括资助新诊断技术的研发，以及增加检测和治疗机会的计划。

研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构，评估全球范围内的竞争吸引力。此外，这些工具还对全球艾滋病诊断市场的各个细分市场进行了全面评估。hiv/艾滋病诊断行业的增长和趋势为本研究提供了整体方法。

市场细分：

hiv/艾滋病诊断市场报告的这一部分提供了国家和地区层面细分市场的详细数据，从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 试剂盒
  • 仪器

按检测类型

  • 核酸检测
  • 快速检测（POC）
  • 酶联免疫吸附
  • 其他

按终端用户分类

  • 医院
  • 诊断实验室
  • 学术研究机构
  • 其他

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太、拉美、中东和非洲地区当前和未来的HIV/AIDS诊断市场需求。此外，该报告还重点关注了所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。艾滋病诊断市场的主要参与者包括Hologic公司、雅培公司、Bio-Rad实验室公司、F. Hoffmann-La罗氏有限公司、OraSure技术公司、西门子医疗保健有限公司、Chembio诊断公司、丹纳赫公司、Becton, Dickinson公司。本部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

目 录

第一章：前言

  • 报告描述
    • 报告目标
    • 目标受众
    • 独特销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场调研流程
    • 市场调研方法

第二章：执行摘要

  • 市场亮点
  • 全球市场概况

第三章：HIV/艾滋病诊断 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 行业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分类的市场吸引力分析
    • 按测试类型的市场吸引力分析
    • 按最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商列表
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道发展趋势

第五章：COVID-19爆发的影响分析

第六章：全球艾滋病诊断市场分析：按产品分类

  • 产品概述
  • 历史和预测数据
  • 按产品分析
  • 试剂盒和试剂
  • 仪器

第七章 ：全球HIV/艾滋病诊断市场分析：按检测类型划分

  • 按检测类型概述
  • 历史和预测数据
  • 按检测类型分析
  • 核酸检测
  • 快速检测（POC）
  • 酶联免疫吸附试验
  • 其他

第八章：全球艾滋病诊断市场销售分析：按最终用户分类

  • 终端用户概述
  • 历史和预测数据
  • 按最终用户分析
  • 医院
  • 诊断实验室
  • 学术研究机构
  • 其他

第九章：全球HIV/AIDS诊断市场销售分析：按地区划分

  • 地区展望 销售分析
  • 销售分析
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美地区销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区各细分市场销售分析
    • 亚太地区各国销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东及非洲地区销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第十章：HIV/AIDS诊断产品企业竞争格局

  • 艾滋病诊断市场竞争格局
  • 伙伴关系/合作/协议
  • 合并与收购
  • 新产品上市
  • 其他发展

第十一章 ：公司概况

  • 前10强企业份额分析
  • 市场集中率
  • Hologic Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Abbott
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Bio-Rad Laboratories Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • F. Hoffmann-La Roche Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • OraSure Technologies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Siemens Healthcare GmbH
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Chembio Diagnostics Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Danaher Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Becton
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展
  • Dickinson and Company
    • 公司概况
    • 公司收入
    • 产品
    • 近期发展

*注：在公司概况中，财务细节和近期发展取决于可用性，如果是私营公司，则可能不包括在内。

Product Code: VMR112110619

The global demand for HIV/AIDS Diagnostics Market is presumed to reach the market size of nearly USD 13.75 BN by 2030 from USD 6.22 BN in 2022 with a CAGR of 10.42% under the study period 2023 - 2030.

HIV/AIDS diagnostics refer to the tests and methods used to detect the presence of the human immunodeficiency virus (HIV) and monitor the progression of acquired immunodeficiency syndrome (AIDS). These diagnostics include various laboratory tests and point-of-care (POC) devices that can detect HIV antibodies or antigens, viral load, and CD4 T-cell count.

Market Dynamics:

Despite significant progress in HIV/AIDS prevention and treatment, the disease remains a major global health challenge. There were an estimated 38 million people living with HIV/AIDS worldwide in 2019 (WHO report). This high prevalence of HIV/AIDS is driving the demand for diagnostics that can accurately detect and monitor the disease. As healthcare systems improve and become more accessible in low- and middle-income countries, more people are being tested for HIV/AIDS. This is leading to a greater demand for affordable, accurate, and easy-to-use diagnostic tests. Recent advancements in diagnostic technology have led to the development of more sensitive and specific tests for HIV/AIDS. For example, new POC devices can deliver rapid results with high accuracy, allowing for earlier diagnosis and treatment. Self-testing for HIV/AIDS is becoming more popular, particularly in countries with high HIV/AIDS prevalence. Self-testing allows individuals to test themselves in the privacy of their own home, without the need for a healthcare provider. This has scaled up self-testing kits demand as they are accurate, affordable, and easy to use. Governments and international organizations are investing in initiatives to improve HIV/AIDS diagnosis and treatment. This includes funding for research and development of new diagnostic technologies, as well as programs to increase access to testing and treatment.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of hiv/aids diagnostics. The growth and trends of hiv/aids diagnostics industry provide a holistic approach to this study.

Market Segmentation:

This section of the hiv/aids diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Kits And Reagents
  • Instruments

By Test Type

  • Nucleic Acid Tests
  • Rapid Tests (POC)
  • ELISA
  • Others

By End-User

  • Hospitals
  • Diagnostic Laboratories
  • Academic And Research Institutes
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the HIV/AIDS Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hiv/aids diagnostics market include Hologic Inc., Abbott, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., OraSure Technologies Inc., Siemens Healthcare GmbH, Chembio Diagnostics Inc., Danaher Corporation, Becton, Dickinson and Company. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HIV/AIDS DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Test Type
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL HIV/AIDS DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Kits And Reagents Historic and Forecast Sales by Regions
  • 6.5 Instruments Historic and Forecast Sales by Regions

7 . GLOBAL HIV/AIDS DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

  • 7.1 Overview by Test Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Test Type
  • 7.4 Nucleic Acid Tests Historic and Forecast Sales by Regions
  • 7.5 Rapid Tests (POC) Historic and Forecast Sales by Regions
  • 7.6 ELISA Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL HIV/AIDS DIAGNOSTICS MARKET SALES ANALYSIS BY END-USER

  • 8.1 Overview by End-user
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-user
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 8.6 Academic And Research Institutes Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL HIV/AIDS DIAGNOSTICS MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HIV/AIDS DIAGNOSTICS COMPANIES

  • 10.1. Hiv/Aids Diagnostics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF HIV/AIDS DIAGNOSTICS INDUSTRY

  • 11.1. Top 10  Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Hologic Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Abbott
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Bio-Rad Laboratories Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. F. Hoffmann-La Roche Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. OraSure Technologies Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Siemens Healthcare GmbH
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Chembio Diagnostics Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Danaher Corporation
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Becton
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Dickinson and Company
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments

 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Analysis by Product (USD MN)
  •  Kits And Reagents Market Sales by Geography (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Analysis Market by Test Type (USD MN)
  •  Nucleic Acid Tests Market Sales by Geography (USD MN)
  •  Rapid Tests (POC) Market Sales by Geography (USD MN)
  •  ELISA Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by End-user (USD MN)
  •  Hospitals Market Sales by Geography (USD MN)
  •  Diagnostic Laboratories Market Sales by Geography (USD MN)
  •  Academic And Research Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Hiv/Aids Diagnostics Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition

LIST OF FIGURES

  •  Research Scope of Hiv/Aids Diagnostics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Hiv/Aids Diagnostics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Test Type
  •  Market Attractiveness Analysis by End-user
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product (USD MN)
  •  Kits And Reagents Market Sales by Geography (USD MN)
  •  Instruments Market Sales by Geography (USD MN)
  •  Global Market Analysis by Test Type (USD MN)
  •  Nucleic Acid Tests Market Sales by Geography (USD MN)
  •  Rapid Tests (POC) Market Sales by Geography (USD MN)
  •  ELISA Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by End-user (USD MN)
  •  Hospitals Market Sales by Geography (USD MN)
  •  Diagnostic Laboratories Market Sales by Geography (USD MN)
  •  Academic And Research Institutes Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis

 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.